Also trades as: GLAB.CN (CNQ) · $vol 0M
GLABF OTC
Gemina Laboratories Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -85.1%
3Y: -90.5%
$0.05
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$113K
-21.3% ▼
Operating Income
-$4M
+23.1% ▲
Net Income
-$4M
+21.9% ▲
EPS (Diluted)
$-0.06
+23.6% ▲
EBITDA
-$4M
+26.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $12K | $44K | $50K | $93K | $113K |
| Gross Profit | -$12K | -$44K | -$50K | -$93K | -$113K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $508K | $3M | $4M | $2M | $1M |
| SG&A Expenses | $125K | $2M | $2M | $3M | $3M |
| Operating Expenses | $634K | $5M | $6M | $5M | $4M |
| Operating Income | -$646K | -$5M | -$6M | -$5M | -$4M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $2K | $539 | $0 | $19K | $164K |
| Income Before Tax | -$834K | -$5M | -$6M | -$5M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$834K | -$5M | -$6M | -$5M | -$4M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.02 | $-0.10 | $-0.10 | $-0.07 | $-0.06 |
| EBITDA | -$634K | -$5M | -$6M | -$5M | -$4M |
| Shares Outstanding | 50M | 48M | 60M | 72M | 74M |